• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非阵发性心房颤动中的非肺静脉触发灶:病理生理学对导管消融的影响

Non-pulmonary vein triggers in nonparoxysmal atrial fibrillation: Implications of pathophysiology for catheter ablation.

作者信息

Della Rocca Domenico G, Tarantino Nicola, Trivedi Chintan, Mohanty Sanghamitra, Anannab Alisara, Salwan Anu S, Gianni Carola, Bassiouny Mohamed, Al-Ahmad Amin, Romero Jorge, Briceño David F, Burkhardt J David, Gallinghouse G Joseph, Horton Rodney P, Di Biase Luigi, Natale Andrea

机构信息

Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas.

Arrhythmia Services, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.

出版信息

J Cardiovasc Electrophysiol. 2020 Aug;31(8):2154-2167. doi: 10.1111/jce.14638. Epub 2020 Jul 6.

DOI:10.1111/jce.14638
PMID:32583488
Abstract

Rhythm control of persistent atrial fibrillation (AF) patients represents a challenge for the modern interventional cardiac electrophysiologist; as a matter of fact, there is still divergence regarding the best ablative approach to adopt in this population. Different investigational endpoints, variability of techniques and tools, significant technological evolution, and the lack of universally accepted pathophysiological models engendered a considerable heterogeneity in terms of techniques and outcomes, so much that the treatment of persistent subtypes of AF commonly still relies mainly on pulmonary vein (PV) isolation. The purpose of the present review is to report the current experimental and clinical evidence supporting the importance of mapping and ablating non-PV triggers and describe our institutional approach for the ablation of nonparoxysmal AF.

摘要

对于现代介入心脏电生理学家而言,持续性心房颤动(AF)患者的节律控制是一项挑战;事实上,对于该人群应采用的最佳消融方法仍存在分歧。不同的研究终点、技术和工具的可变性、重大的技术进步,以及缺乏普遍接受的病理生理模型,导致在技术和结果方面存在相当大的异质性,以至于持续性AF亚型的治疗目前通常仍主要依赖肺静脉(PV)隔离。本综述的目的是报告支持标测和消融非PV触发灶重要性的当前实验和临床证据,并描述我们机构针对非阵发性AF的消融方法。

相似文献

1
Non-pulmonary vein triggers in nonparoxysmal atrial fibrillation: Implications of pathophysiology for catheter ablation.非阵发性心房颤动中的非肺静脉触发灶:病理生理学对导管消融的影响
J Cardiovasc Electrophysiol. 2020 Aug;31(8):2154-2167. doi: 10.1111/jce.14638. Epub 2020 Jul 6.
2
Beyond Pulmonary Vein Isolation in Nonparoxysmal Atrial Fibrillation: Posterior Wall, Vein of Marshall, Coronary Sinus, Superior Vena Cava, and Left Atrial Appendage.非阵发性心房颤动的肺静脉隔离以外:后间隔壁、Marshall 静脉、冠状窦、上腔静脉和左心耳。
Card Electrophysiol Clin. 2020 Jun;12(2):219-231. doi: 10.1016/j.ccep.2020.01.002.
3
Catheter Ablation of Paroxysmal Atrial Fibrillation: Have We Achieved Cure with Pulmonary Vein Isolation?阵发性心房颤动的导管消融:肺静脉隔离能实现治愈吗?
Methodist Debakey Cardiovasc J. 2015 Apr-Jun;11(2):71-5. doi: 10.14797/mdcj-11-2-71.
4
Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes.高龄患者心房颤动的导管消融治疗:安全性和结局。
J Cardiovasc Electrophysiol. 2012 Jul;23(7):687-93. doi: 10.1111/j.1540-8167.2012.02293.x. Epub 2012 Apr 11.
5
Catheter Ablation for Long-Standing Persistent Atrial Fibrillation.长期持续性心房颤动的导管消融治疗
Methodist Debakey Cardiovasc J. 2015 Apr-Jun;11(2):87-93. doi: 10.14797/mdcj-11-2-87.
6
Techniques for the provocation, localization, and ablation of non-pulmonary vein triggers for atrial fibrillation.房颤非肺静脉触发灶的激发、定位和消融技术。
Heart Rhythm. 2017 Jul;14(7):1087-1096. doi: 10.1016/j.hrthm.2017.02.030. Epub 2017 Mar 2.
7
Novel concepts and approaches in ablation of atrial fibrillation: the role of non-pulmonary vein triggers.新型概念和方法在房颤消融中的应用:非肺静脉触发灶的作用。
Europace. 2018 Oct 1;20(10):1566-1576. doi: 10.1093/europace/euy034.
8
Prevalence of right atrial non-pulmonary vein triggers in atrial fibrillation patients treated with thyroid hormone replacement therapy.接受甲状腺激素替代治疗的心房颤动患者右心房非肺静脉触发灶的患病率。
J Interv Card Electrophysiol. 2017 Aug;49(2):111-117. doi: 10.1007/s10840-017-0234-x. Epub 2017 Mar 7.
9
Targeting nonpulmonary vein triggers during atrial fibrillation ablation: is the game worth the candle?心房颤动消融术中针对非肺静脉触发灶:此举是否值得?
Curr Opin Cardiol. 2018 Jan;33(1):50-57. doi: 10.1097/HCO.0000000000000469.
10
Recurrent Atrial Fibrillation with Isolated Pulmonary Veins: What to Do.孤立性肺静脉的复发性心房颤动:该如何处理。
Card Electrophysiol Clin. 2020 Jun;12(2):209-217. doi: 10.1016/j.ccep.2020.02.001.

引用本文的文献

1
Impact of the first-pass pulmonary vein isolation on ablation outcomes in persistent atrial fibrillation.首次通过肺静脉隔离对持续性心房颤动消融结果的影响。
Front Cardiovasc Med. 2025 Jun 5;12:1588716. doi: 10.3389/fcvm.2025.1588716. eCollection 2025.
2
Pulsed-field ablation beyond pulmonary vein for persistent atrial fibrillation: efficacy and impact on left atrial function.肺静脉以外区域的脉冲场消融治疗持续性心房颤动:疗效及对左心房功能的影响
J Interv Card Electrophysiol. 2025 Jun 2. doi: 10.1007/s10840-025-02080-1.
3
Beyond Pulmonary Vein Reconnection: Exploring the Dynamic Pathophysiology of Atrial Fibrillation Recurrence After Catheter Ablation.
超越肺静脉隔离:探索导管消融术后房颤复发的动态病理生理学
J Clin Med. 2025 Apr 23;14(9):2919. doi: 10.3390/jcm14092919.
4
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.2024年欧洲心律协会/心律协会/亚太心律协会/拉丁美洲心律协会关于心房颤动导管消融和外科消融的专家共识声明
J Arrhythm. 2024 Oct 6;40(6):1217-1354. doi: 10.1002/joa3.13082. eCollection 2024 Dec.
5
Multielectrode catheter-based pulsed field ablation of persistent and long-standing persistent atrial fibrillation.基于多电极导管的脉冲电场消融治疗持续性和长期持续性心房颤动。
Europace. 2024 Oct 3;26(10). doi: 10.1093/europace/euae246.
6
The Value of Adjunctive Left Atrial Posterior Wall Isolation on Clinical Outcomes in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis.辅助性左心房后壁隔离术对房颤患者临床结局的价值:一项系统评价与Meta分析
Rev Cardiovasc Med. 2024 Jun 5;25(6):210. doi: 10.31083/j.rcm2506210. eCollection 2024 Jun.
7
Mechanistic Insights From Trials of Atrial Fibrillation Ablation: Charting a Course for the Future.从房颤消融试验中获得的机制见解:为未来规划路线。
Circ Arrhythm Electrophysiol. 2024 Aug;17(8):e012939. doi: 10.1161/CIRCEP.124.012939. Epub 2024 Jul 23.
8
Atypical Antiadrenergic Effect of Refralon as a Mechanism of High Antiarrhythmic Effectiveness.Refralon 的非典型抗肾上腺素作用是其高效抗心律失常作用的机制。
Bull Exp Biol Med. 2024 May;177(1):57-62. doi: 10.1007/s10517-024-06131-x. Epub 2024 Jul 2.
9
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.2024 年欧洲心律协会/心律学会/亚太心律学会/拉丁美洲心律学会专家共识声明:关于心房颤动的导管和手术消融。
J Interv Card Electrophysiol. 2024 Aug;67(5):921-1072. doi: 10.1007/s10840-024-01771-5.
10
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.2024 年欧洲心脏节律协会/心律学会/亚太心脏节律学会/拉丁美洲心脏节律学会专家共识声明:导管和手术消融治疗心房颤动。
Europace. 2024 Mar 30;26(4). doi: 10.1093/europace/euae043.